Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.242 | Prevalence of Nonalcoholic fatty liver disease among Chinese patients with morbid obesity and the effect of bariatric surgery on liver fibrosis | Dr. WONG Wai Sun |
| 2008.328 | Treatment of Nonalcoholic Fatty Liver Disease with Probiotics & Prebiotics | Dr Wong Wai Sun |
| 2008.134 | A Prospective Cohort Study on Chronic Hepatitis B Patients with Suboptimal Virologic Response to Oral Antiviral Drugs | Dr Wong Wai Sun |
| 2012.424 | Prevalence and clinical significance of nonalcoholic fatty liver disease in patients with type 2 diabetes: A prospective cohort study using controlled attenuation parameter and liver stiffness measurements | Dr. WONG Wai Sun |
| 2008.445 | Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease | Dr Wong Wai Sun |
| 2007.485 | Prevalence of Colorectal neoplasm among Patients with Nonalcoholic Fatty Liver Disease - A Cross-Sectional Study (NAFLD-Colon Study) | Dr Wong Wai Sun |
| 2011.432 | Consolidation of lifestyle modification for nonalcoholic fatty liver disease by information technology | Dr Wong Wai Sun |
| 2014.252 | Investigation on the Treatment Effectiveness of Unloader One_ Knee Brace for Paitents with Knee Osteoarthritis | Mr WONG Wai Man |
| 2021.179 | The Effects of Multi-modal Intervention in Managing Symptom Cluster of Cancer-Related Fatigue-Sleeping Problem-Depressed Mood in Breast Cancer Patients undergoing Chemotherapy: A Randomized Controlled Trial |
Ms. WONG Wai Man 黃慧敏 |
| 2007.489 | A Restrospective Study in Exploring the Effectiveness of ED Nurse-Initiated Asthma Protocol: Optimizing the Clinical Outcomes of Adult Asthma Patients | Dr. WONG Wai Lin Marian |
| 2017.330 | An exploratory study on effects of self efficacy and interpersonal interaction on exercise adherence in Patients with chronic pain |
Mr. WONG Wai Lam 黃韋霖 |
| 2008.055 | The Effectiveness of Hand-washing Program on Compliance with Hand Hygiene for Visiting Parents in Neonatal Unit | Ms Wong Wai Fong |
| 2012.195 | Laparoscopic total extraperitoneal inguinal hernia repair under spinal anaesthesia in patients who are unfit for general anaesthesia | Dr. WONG Vivien Wai Yin |
| 2015.008 | Comparison of Outcome and Complications of Anterior versus Posterior Approach in Per-oral Endoscopic Myotomy (POEM) Procedure for Treatment of Achalasia: Randomized Single Blinded Clinical Trial | Dr. WONG Vivien Wai Yin |
| 2021.369 | Enhancing Group Lifestyle Intervention for Depression with Self-Tracking Tools: A Randomized Pilot Controlled Trial |
Mr. WONG Vincent Wing Hei 黃穎僖 |
| 2019.697 | Effect of a Culturally Adapted Self-help Smartphone-based Lifestyle Intervention in Reducing Depressive Symptoms: A Randomized Controlled Trial |
Mr. WONG Vincent Wing Hei 黃穎僖 |
| 2019.381 | A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of VIR-2218 Alone or in Combination with Pegylated Interferon Alpha-2a | Prof. WONG Vincent Wai Sun |
| 2017.163 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2016.606 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2016.698 | Non-invasive diagnosis and prognosis of nonalcoholic steatohepatitis and liver fibrosis: A clinicopathological study of metabolite, lipid, and protein biomarkers |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2017.511 | Biomarkers study on biological samples from NAFLD and NASH patients from the biobank at the Chinese University of Hong Kong |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2014.586 | CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects with Liver Fibrosis | Prof. WONG Vincent Wai Sun |
| 2017.611 | A 12-week randomized, patient and investigator blinded, placebo-controlled, parallel group study to investigate the efficacy of LIK066 in obese patients with non-alcoholic steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.166 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.001 | Optimizing varices screening in cirrhotic patients with well-controlled chronic viral hepatitis: A prospective cohort study with transient elastography and multiparametric magnetic resonance imaging |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2017.257 | Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2017.258 | AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2019.415 | A Phase 2b, Multicenter, Double-blind, Active Controlled, Randomized Study to Investigate the Efficacy and Safety of different combination regimens including JNJ-73763989 and/or JNJ-56136379 for the treatment of Chronic Hepatitis B Virus Infection | Prof. WONG Vincent Wai Sun |
| 2020.602 | A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis |
Prof. WONG Vincent Wai Sun 黃煒燊教授 |
| 2020.303 | A Phase 2, Randomized, Double-blind, Double-dummy, Placebo-controlled, Dose-ranging, Dose-finding, Parallel Group Study to Assess Efficacy and Safety of PF 06865571 (DGAT2i) Alone and When Coadministered with PF-05221304 (ACCi) in Adult Participants with Biopsy-confirmed Nonalcoholic Steatohepatitis and Fibrosis Stage 2 or 3 |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2018.301 | A Registry Study to Assess Patient Reported Outcomes (PRO’s) in Patients with Liver Diseases (CLD-PRO Global Registry Study) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2020.306 | Evaluation of Efficacy, Safety and Tolerability of NGM282 (Aldafermin) in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE 4) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2018.151 | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2006.439 | Collection of Blood and Liver Biopsy Samples for Liver Fibrosis Study | Dr. WONG Vincent Wai Sun |
| 2023.183 | A Randomised, Double-blind, Placebo-controlled, Multi-centre Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 in Participants with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) with Fibrosis Who Are Carriers of the PNPLA3 rs738409 148M Risk Allele | Prof. WONG Vincent Wai Sun |
| 2023.249 | A Phase 2b Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults With Precirrhotic Nonalcoholic Steatohepatitis | Prof. WONG Vincent Wai Sun |
| 2021.189 | Multicenter, double-blind, parallel-group, randomised, 48 weeks, dose-ranging, placebo-controlled phase II trial to evaluate efficacy, safety and tolerability of multiple subcutaneous (s.c.) doses of BI 456906 in patients with non-alcoholic steatohepatitis (NASH) and fibrosis |
Prof. WONG Vincent Wai Sun 黃煒燊教授 |
| 2023.182 | A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of HTD1801 in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis who Have Type 2 Diabetes or Pre-Diabetes (The CENTRICITY Study) | Prof. WONG Vincent Wai Sun |
| 2024.124 | Assessing the safety of discontinuing non-selective beta-blockers in cirrhotic patients with managed primary aetiological factors according to Baveno VII consensus |
Professor Wong Vincent Wai Sun 黃煒燊 |
| 2024.292 | A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2024.591 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF DR10624 INJECTION IN SUBJECTS AT HIGH RISK OF LIVER FIBROSIS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND METABOLIC DYSFUNCTION AND ALCOHOL ASSOCIATED STEATOTIC LIVER DISEASE | Prof. WONG Vincent Wai Sun |
| 2024.451 | A randomised, double-blind, placebo-controlled, multicentre, Phase III trial evaluating long-term efficacy and safety of survodutide weekly injections in adult participants with non-cirrhotic non-alcoholic steatohepatitis/metabolic associated steatohepatitis (NASH/MASH) and (F2) - (F3) stage of liver fibrosis |
Prof. WONG Vincent Wai Sun Wai Sun Vincent Wong |
| 2024.440 | A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis |
Prof. WONG Vincent Wai Sun Wai Sun Vincent Wong |
| 2024.371 | A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) |
Prof. WONG Vincent Wai Sun Vincent Wai Sun Wong |
| 2017.422 | A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Subjects with Primary Biliary Cholangitis |
Prof. WONG Vincent W.S. 黃偉燊 |
| 2003.338 | A Study on Nonalcoholic Steatohepatitis (NASH) in Hong Kong | Prof. WONG Vincent W.S. |
| 2013.678 | Brown adipose tissue and body fat distribution in non-alcoholic steatohepatitis: A clinicopathological study using fat-water magnetic resonance imaging | Dr Wong Vincent |
| 2025.071 | Prevalence and clinical significance of detectable blood phosphatidylethanol in patients with metabolic dysfunction-associated steatotic liver disease and chronic hepatitis B |
Dr. WONG Vincent Vincent Wong |
| 2013.677 | Consolidation of lifestyle modification program with mobile phone text messaging in patients with non-alcoholic fatty liver disease: A randomized controlled trial | Dr Wong Vincent |
| 2019.136 | Characterization of biology of nonalcoholic fatty liver disease by single-cell RNA sequencing |
Dr. WONG Vincent 黃煒燊 |
Page 24 of 262.